Sinopep-Allsino Biopharmaceutical Co. Ltd. A (688076) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.022x

Based on the latest financial reports, Sinopep-Allsino Biopharmaceutical Co. Ltd. A (688076) has a cash flow conversion efficiency ratio of 0.022x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥68.66 Million ≈ $10.05 Million USD) by net assets (CN¥3.13 Billion ≈ $458.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 688076 net asset quality index to measure how much of total assets are equity-financed.

Sinopep-Allsino Biopharmaceutical Co. Ltd. A - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Sinopep-Allsino Biopharmaceutical Co. Ltd. A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Sinopep-Allsino Biopharmaceutical Co. Lt to evaluate the quality of earnings relative to operating cash generation.

Sinopep-Allsino Biopharmaceutical Co. Ltd. A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sinopep-Allsino Biopharmaceutical Co. Ltd. A ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Kunshan Kersen Science & Tech SHG:603626	0.055x
Telling Telecommunication Holding Co Ltd SHE:000829	-0.232x
ATAI Life Sciences NV XETRA:9VC	-0.145x
Universal Corporation NYSE:UVV	0.128x
Novavax Inc NASDAQ:NVAX	0.224x
Xi'an Sinofuse Electric Co. Ltd. SHE:301031	N/A
Triumph Financial, Inc. NASDAQ:TFIN	0.027x
Suzhou Good-Ark Electronics Co Ltd SHE:002079	0.025x

Annual Cash Flow Conversion Efficiency for Sinopep-Allsino Biopharmaceutical Co. Ltd. A (2013–2025)

The table below shows the annual cash flow conversion efficiency of Sinopep-Allsino Biopharmaceutical Co. Ltd. A from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Sinopep-Allsino Biopharmaceutical Co. Lt worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥3.00 Billion ≈ $439.25 Million	CN¥681.24 Million ≈ $99.69 Million	0.227x	+52.14%
2024-12-31	CN¥2.68 Billion ≈ $392.51 Million	CN¥400.12 Million ≈ $58.55 Million	0.149x	-6.75%
2023-12-31	CN¥2.19 Billion ≈ $320.36 Million	CN¥350.21 Million ≈ $51.25 Million	0.160x	+951.19%
2022-12-31	CN¥1.92 Billion ≈ $281.67 Million	CN¥29.29 Million ≈ $4.29 Million	0.015x	-84.77%
2021-12-31	CN¥1.81 Billion ≈ $264.68 Million	CN¥180.75 Million ≈ $26.45 Million	0.100x	-31.72%
2020-12-31	CN¥966.02 Million ≈ $141.36 Million	CN¥141.38 Million ≈ $20.69 Million	0.146x	+166.14%
2019-12-31	CN¥838.98 Million ≈ $122.77 Million	CN¥46.14 Million ≈ $6.75 Million	0.055x	-55.04%
2018-12-31	CN¥785.38 Million ≈ $114.93 Million	CN¥96.06 Million ≈ $14.06 Million	0.122x	+253.60%
2017-12-31	CN¥321.20 Million ≈ $47.00 Million	CN¥11.11 Million ≈ $1.63 Million	0.035x	+105.51%
2016-12-31	CN¥34.95 Million ≈ $5.11 Million	CN¥-21.95 Million ≈ $-3.21 Million	-0.628x	+59.12%
2015-12-31	CN¥73.32 Million ≈ $10.73 Million	CN¥-112.62 Million ≈ $-16.48 Million	-1.536x	+51.62%
2014-12-31	CN¥-21.47 Million ≈ $-3.14 Million	CN¥68.18 Million ≈ $9.98 Million	-3.175x	-126.79%
2013-12-31	CN¥3.69 Million ≈ $539.29K	CN¥43.67 Million ≈ $6.39 Million	11.850x	--

About Sinopep-Allsino Biopharmaceutical Co. Ltd. A

SHG:688076 China Biotechnology

Market Cap

$1.27 Billion

CN¥8.70 Billion CNY

Market Cap Rank

#7852 Global

#1778 in China

Share Price

CN¥27.52

Change (1 day)

-1.15%

52-Week Range

CN¥26.25 - CN¥46.88

All Time High

CN¥90.43